Wegovy is now widely available in Canada, and many people are asking the same question: who actually qualifies for it?

Wegovy is a once-weekly injection that contains semaglutide, the same active ingredient as Ozempic, but at a higher dose and approved specifically for weight management.

If you have been thinking about whether Wegovy might be right for you, the first step is understanding the eligibility requirements set by Health Canada and applied by clinicians across the country.

Wegovy eligibility in Canada is built on a clear set of medical criteria, mostly centered on body mass index (BMI), weight-related health conditions, and your overall safety profile. The decision to prescribe is not just about a number on the scale. Your doctor will look at the bigger picture, including your medical history, current medications, and personal goals.

This guide walks through the Wegovy approval status in Canada, the BMI thresholds and other Wegovy Canada requirements, who is not a good candidate, and how to actually get prescribed Wegovy through your family doctor or a Canadian telehealth provider. We finish with what to expect during an eligibility assessment and how to think about cost and coverage.

Note: This article is for general information only. It does not replace personalized medical advice. If you are considering Wegovy, please speak with your doctor or a clinician on the myrocky.ca platform to confirm whether it is right for you.

What Is Wegovy?

Wegovy is the brand name for semaglutide 2.4 milligrams, a once-weekly injection in the GLP-1 receptor agonist family. It mimics a natural gut hormone that helps regulate blood sugar, slows the rate at which your stomach empties, and signals fullness to the brain. The result is a lower appetite, reduced cravings, and a more comfortable path to eating less without constant willpower battles.

Is Wegovy Similar to Ozempic?

Although Wegovy and Ozempic share the same active molecule, they are approved for different conditions. Ozempic is approved for adults with type 2 diabetes, while Wegovy is approved for chronic weight management. Wegovy is also dosed at a higher maximum strength, which mirrors the doses used in the major obesity clinical trials.

Is Wegovy Approved in Canada for Weight Loss?

Yes. Wegovy received approval from Health Canada in November 2021 and became commercially available across the country on May 6, 2024 after a period of supply ramp-up by Novo Nordisk.

In November 2024, Health Canada also expanded the approval to include reducing the risk of a heart attack in adults with established cardiovascular disease and a BMI of at least 27.

In short, Wegovy is approved in Canada for weight loss, which means a clinician can prescribe it on-label without needing to use it off-label the way Ozempic is sometimes used for weight management. That official Wegovy approval in Canada is the legal basis for the prescription pathway you will see at clinics and on telehealth platforms.

Wegovy Eligibility in Canada: BMI and Health Requirements

BMI Thresholds

The Wegovy product monograph and the Canadian Adult Obesity Clinical Practice Guidelines describe the same eligibility criteria:

• A body mass index of 30 or higher, classified as obesity, or
• A body mass index of 27 or higher, classified as overweight, together with at least one weight-related health condition.

These thresholds form the foundation of who qualifies for Wegovy in Canada. They are not a hard pass or fail, but they tell your doctor whether the expected benefits of the medication outweigh the typical risks. The BMI for Wegovy is the same standard used in the clinical trials that earned the drug its Canadian approval.

Weight-Related Conditions

Examples of weight-related conditions that can support Wegovy eligibility include the following:

• Type 2 diabetes or prediabetes
• High blood pressure
• High cholesterol or high triglycerides
• Obstructive sleep apnea
• Polycystic ovary syndrome
• Fatty liver disease
• Established cardiovascular disease, which now meets criteria for the heart attack risk reduction indication

If your BMI is between 27 and 29.9 and you do not have one of these conditions, your clinician may decide Wegovy is not the right choice yet. If you do have one or more, the clinical case for treatment becomes stronger.

Who Qualifies for Wegovy Beyond BMI?

BMI is a starting point, not the entire test. Canadian doctors also consider:

• Your weight history, including past attempts at weight loss and how your body responded.
• Family history of obesity, diabetes, or heart disease.
• Lifestyle factors such as nutrition, sleep, and physical activity.
• Mental health and any history of disordered eating.
• Other medications you take and how they may interact with semaglutide.
• Whether you can attend follow-up visits and access lab work as needed.

This is why a quick chat with a friend or a checkbox on a website is not enough. A proper Wegovy eligibility assessment in Canada involves a clinician reviewing your full picture and confirming that the medication fits your needs and your safety profile.

Who Should Not Take Wegovy

Wegovy is not suitable for everyone. The product monograph lists clear contraindications and important cautions. You may not be a candidate if any of the following apply:

• You have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• You have had a serious allergic reaction to semaglutide or any ingredient in Wegovy.
• You are pregnant, planning pregnancy within two months, or breastfeeding.
• You have a history of pancreatitis, severe gastroparesis, or active gallbladder disease.
• You are using another GLP-1 receptor agonist or a separate semaglutide product.
• You have severe kidney or liver disease that requires extra caution.

Other situations call for monitoring rather than refusal. Your doctor will weigh the benefits and risks based on your unique profile and may recommend lab work before starting.

Do You Need a Prescription for Wegovy in Canada?

Yes. A Wegovy prescription in Canada is required, and the medication is not available over the counter. Reputable pharmacies will not dispense Wegovy without a valid Canadian prescription written by an authorized healthcare professional, such as a family physician, an internist, an endocrinologist, or a nurse practitioner.

This rule exists for good reason. Wegovy is a powerful medication with real risks, and taking it without proper medical screening can cause harm. A Health Canada-approved prescription pathway protects you, ensures the right starting dose, and supports you through the gradual dose escalation process.

How to Get Prescribed Wegovy in Canada

In Person With Your Family Doctor

If you already have a family doctor, the most direct route is to book a weight management appointment. Bring a list of your current medications, recent blood work if you have it, and a clear summary of what you have already tried. Your doctor will check your BMI, ask about weight-related conditions, and discuss whether Wegovy fits your goals and your risk profile.

Through Telehealth

Many Canadians do not have a regular family doctor or simply prefer the convenience of a virtual visit. Can telehealth doctors prescribe Wegovy in Canada? Yes, provided they are licensed in your province and follow the same clinical standards as an in-person clinic.

Platforms like myrocky.ca connect you with Canadian-licensed clinicians who complete the same eligibility review and write a Wegovy prescription if it is appropriate.

Telehealth is especially helpful for people in smaller communities, those balancing work and caregiving, and anyone who feels more comfortable discussing weight in a private virtual setting. Just make sure you choose a platform that uses Canadian-licensed providers and a Canadian pharmacy.

What to Expect During the Eligibility Assessment

A typical Wegovy eligibility assessment in Canada usually includes the following steps. The assessment may include:

• A questionnaire about your weight history, health conditions, and goals.
• A measurement of your height and weight to calculate BMI, either at the clinic or self-reported through a verified process.
• A review of your current medications and any allergies.
• A discussion of side effects and what the first few weeks of treatment typically feel like.
• A plan for follow-up visits and dose escalation.
• Optional lab work such as fasting glucose, HbA1c, lipid panel, kidney function, and thyroid function.

At the end of the visit, your clinician will let you know whether you qualify, recommend an alternative if you do not, and explain how to fill the prescription, store the pen, and inject it safely. You will also receive guidance on titrating up gradually, which helps minimize side effects like nausea.

Wegovy Cost and Coverage

Wegovy is not currently covered by most provincial drug plans for weight loss. Some private workplace insurance plans now reimburse it, often with prior authorization based on BMI and weight-related conditions. Out-of-pocket cost is typically around 400 Canadian dollars for a 28-day supply at the maintenance dose, though pharmacy pricing and dose stage can shift the number.

If cost is a concern, ask your clinician whether your benefit plan covers obesity treatment, whether a slower titration could lower your monthly cost in the early months, and whether other Health Canada-approved options may suit your situation. Some patients also benefit from asking the prescribing clinic about ongoing coaching, because lifestyle support tends to improve results and protect them over time.

Where to Go from Here

At myrocky.ca, our Canadian-licensed clinicians review your full profile, confirm whether you meet Wegovy eligibility, and walk you through the next steps if you do. The process starts with a simple online weight loss assessment, and you can always read more on the myrocky blog before you commit.

Wegovy can be a powerful part of a long-term health plan when it is prescribed for the right person, at the right time, alongside the right support. If you are wondering whether you qualify, the most reliable answer comes from a clinician who knows your story, not from a checklist on the internet.

References

1. Novo Nordisk Canada. “Wegovy (semaglutide injection) Product Monograph.” 2024.
2. CBC News. “Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk.” November 2024.
3. Wharton, S., et al. “Obesity in Adults: A Clinical Practice Guideline.” CMAJ, vol. 192, no. 31, 2020, E875–E891.
4. Maple. “Wegovy Prescription Online in Canada.” 2024.
5. Obesity Canada. “5As Framework for Obesity Management in Adults.” 2020.
6. Health Canada. “Regulatory Decision Summary for Wegovy.” Drug and Health Products Portal.

Disclaimer: This article is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider with any questions about a medical condition or treatment.

Editorial Standards: At Rocky Health, we’ve made it our mission to support men and women with trustworthy, easy-to-understand medical and health information online. Read more about our editorial standards here.